ACM
MREO

Aquatic Capital Management’s Mereo BioPharma MREO Stock Holding History

Aquatic Capital Management’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,216
Closed -$8.84K – 1656
2025
Q4 		$8.84K Sell
21,216
-32,496
-61% -$61.9K ﹤0.01% 1338
2025
Q3 		$111K Buy
53,712
+26,782
+99% +$49.4K ﹤0.01% 1195
2025
Q2 		$73K Buy
+26,930
New +$65K ﹤0.01% 1118
2022
Q1 		– Sell
-5,100
Closed -$8K – 1355
2021
Q4 		$8K Buy
+5,100
New +$10.2K 0.02% 851

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Aquatic Capital Management's MREO Position: Q1 2026 in Review

Aquatic Capital Management sold out of Mereo BioPharma (MREO) in Q1 2026, closing a stake of 21,216 shares — an estimated $8.84K sold.

Aquatic Capital Management first reported a position in MREO in Q4 2021 and held it in 4 quarters. The position peaked at $111K in Q3 2025. 63 funds tracked by Wall St. Rank hold MREO as of Q1 2026.

  • Aquatic Capital Management reported no remaining Mereo BioPharma position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 21,216 Mereo BioPharma shares in Q1 2026, an estimated $8.84K.
  • Aquatic Capital Management first reported a position in Mereo BioPharma in Q4 2021 and held it in 4 quarters.
  • Aquatic Capital Management's Mereo BioPharma position peaked at $111K in Q3 2025.
  • 63 funds tracked by Wall St. Rank held Mereo BioPharma as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.